Bessemer Group Inc Neogenomics Inc Transaction History

Bessemer Group Inc

$65.4 Billion
Q3 2025

A detailed history of Bessemer Group Inc transactions in Neogenomics Inc stock. As of the latest transaction made, Bessemer Group Inc holds 511 shares of NEO stock, worth $5,283. This represents 0.0% of its overall portfolio holdings.

Number of Shares

511

Previous 17 2905.88%

Holding current value

$5,283

Previous $0 Infinity%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 05, 2025	BUY	$4.84 - $8.81 $2,390 - $4,352	494 Added 2905.88%	511 $4,000
Q2 2025 Aug 01, 2025	SELL	$6.4 - $10.27 $4,268 - $6,850	-667 Reduced 97.51%	17 $0
Q1 2025 Apr 23, 2025	SELL	$9.09 - $18.61 $16,807 - $34,409	-1,849 Reduced 73.0%	684 $6,000
Q4 2024 Feb 13, 2025	SELL	$13.0 - $18.43 $118,118 - $167,454	-9,086 Reduced 78.2%	2,533 $42,000
Q3 2024 Nov 12, 2024	SELL	$13.4 - $17.73 $13,158 - $17,410	-982 Reduced 7.79%	11,619 $172,000

Q1 2024 May 13, 2024	SELL	$14.06 - $16.79 $112,480 - $134,320	-8,000 Reduced 38.83%	12,601 $199,000
Q4 2023 Feb 09, 2024	BUY	$11.67 - $20.73 $20,422 - $36,277	1,750 Added 9.28%	20,601 $333,000
Q3 2023 Nov 13, 2023	BUY	$12.15 - $17.85 $34,566 - $50,783	2,845 Added 17.77%	18,851 $231,000
Q2 2023 Aug 10, 2023	BUY	$14.1 - $19.83 $1,480 - $2,082	105 Added 0.66%	16,006 $258,000
Q1 2023 May 10, 2023	BUY	$9.09 - $19.45 $71,820 - $153,674	7,901 Added 98.76%	15,901 $277,000
Q3 2022 Nov 09, 2022	BUY	$7.86 - $12.91 $62,880 - $103,280	8,000 New	8,000 $69,000
Q2 2022 Aug 10, 2022	SELL	$7.06 - $13.97 $713 - $1,410	-101 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$12.15 - $35.28 $1,117 - $3,245	-92 Reduced 47.67%	101 $1,000
Q4 2021 Jan 27, 2022	BUY	$30.49 - $48.49 $2,805 - $4,461	92 Added 91.09%	193 $7,000
Q1 2021 May 13, 2021	SELL	$41.56 - $59.88 $6,608 - $9,520	-159 Reduced 61.15%	101 $4,000
Q4 2020 Feb 09, 2021	BUY	$36.08 - $56.47 $9,380 - $14,682	260 New	260 $14,000
Q3 2019 Nov 07, 2019	SELL	$19.12 - $26.24 $0 - $0	0 Closed	0 $0
Q2 2019 Jul 19, 2019	BUY	$19.57 - $24.1 $0 - $0	0 New	0 $0
Q1 2019 May 13, 2019	SELL	$12.14 - $20.46 $75,268 - $126,852	-6,200 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$11.24 - $18.5 $69,688 - $114,700	6,200 New	6,200 $78,000

Others Institutions Holding NEO

# of Institutions

290

Shares Held

132M

Call Options Held

1.3M

Put Options Held

395K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.3B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Account

Bessemer Group Inc Neogenomics Inc Transaction History